The potential benefits of nalmefene over naloxone carry risk of causing harm. These benefits, if present, should be demonstrated in the clinical environment, balanced with the risks, and compared to naloxone prior to broad adoption of nalmefene.| ACMT
Public health experts have concerns about the opioid reversal agent Opvee. But the company that makes it, Indivior, has found a vocal ally in its marketing of the drug: police.| The Shoestring
NEW YORK – New York Attorney General Letitia James today announced a settlement with Indivior, Inc. (Indivior), a multinational pharmaceutical company, stopping| New York State Attorney General
Independent news for Western Massachusetts that provides in-depth and accurate journalism covering local politics, culture, and power. We bring you the stories, perspectives, and context that no one else does, from Northampton and beyond.| FundRazr
